Poly-L-lactic acid (Sculptra)

Also known as: Sculptra, PLLA, New-Fill, Sculptra Aesthetic

Poly-L-lactic acid (PLLA) is a biodegradable polymer, the same material used in dissolvable sutures, injected as a suspension to trigger the body's own collagen production. Unlike HA filler, it does not add volume directly; correction builds gradually over 2 to 3 months as new collagen forms, and results last around 2 years. The evidence base is solid for facial volume restoration, anchored by four studies in HIV-related facial fat loss (its original FDA approval) and a 2025 systematic review of 20 facial studies. Claims about overall skin quality and tightening rest on weaker data.

How it works

PLLA microparticles injected into the deep dermis or under the skin provoke a controlled foreign-body response: fibroblasts surround the particles and lay down new collagen over weeks to months. The particles themselves fully degrade into lactic acid and are cleared, leaving the new collagen scaffold behind. Because volume comes from your own collagen, results appear slowly across a treatment series rather than instantly.

What the evidence says, claim by claim

These are the results measured in studies, not the results shown in ads. Where the research is weak, the grade says so.

For volume loss

Strong evidence

A 2025 systematic review of 20 clinical studies found PLLA effective and well tolerated for facial volumization and collagen stimulation, with high patient satisfaction and results commonly lasting about 2 years. The deepest data comes from HIV-related facial lipoatrophy, where four prospective studies (VEGA, Chelsea and Westminster, APEX002, Blue Pacific, totaling 278 patients) showed significant, durable increases in dermal thickness sustained at least 18 months. FDA approved for HIV facial lipoatrophy (2004), facial wrinkles and folds (2009), and cheek volume.

Multiple randomized controlled trials or a meta-analysis support this use. The effect is real and repeatable.

Comprehensive Systematic Review of Poly-L-Lactic Acid in Facial Clinical Application (Aesthetic Plastic Surgery, 2025; systematic-review)
Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy (HIV Medicine, 2006; cohort)

For wrinkles and fine lines

Moderate evidence

For nasolabial folds, a multicenter randomized trial with 120-week follow-up compared PLLA head to head with HA filler and found different time courses: HA corrects immediately then fades, while PLLA builds more slowly and holds correction longer, out past 2 years. PLLA suits deeper folds tied to volume loss rather than fine surface lines, which it does not address well.

Randomized trials support this use, but they are few, small, or short. The effect is probably real. The size of it is less certain.

Divergent Time Courses of Poly-L-Lactic Acid and Hyaluronic Acid Fillers for Nasolabial Fold Correction: A Multicenter Randomized Trial With 120-Week Follow-Up (Journal of Craniofacial Surgery, 2026; RCT)

For skin laxity

Limited evidence

PLLA is increasingly marketed for skin firmness and laxity on the face, neck, and body (including off-label buttock treatment) on the logic that new collagen tightens tissue. The 2025 systematic review notes improvements in skin quality measures in some included studies, but these are mostly small, uncontrolled, and secondary to volume outcomes. Randomized evidence that PLLA measurably tightens lax skin is thin.

Only small, short, or lower-quality studies exist. Treat marketing claims about this use with caution.

Comprehensive Systematic Review of Poly-L-Lactic Acid in Facial Clinical Application (Aesthetic Plastic Surgery, 2025; systematic-review)

Risks and what can go wrong

Common effects are injection-site swelling, bruising, and tenderness. The signature delayed risk is small nodules or papules under the skin, historically seen in a meaningful minority of patients; rates dropped substantially with modern technique (higher dilution, longer reconstitution, deep placement, and firm post-treatment massage, often summarized as the rule of 5s). Nodules are usually palpable rather than visible and can persist for months. Not reversible: unlike HA, there is no dissolving enzyme, so poor placement takes months to years to resolve. Practitioner technique drives both results and complication rates. Avoid with active skin infection and a history of keloid or hypertrophic scarring.

The practical details

Typical US pricing is 800 to 1,000 dollars per vial, with 1 to 2 vials per session and 2 to 3 sessions spaced 4 to 6 weeks apart, so full treatment often totals 1,600 to 4,000 dollars or more. Results emerge over 2 to 3 months and last about 2 years, sometimes longer; a single maintenance session every 1 to 2 years is common. FDA approved for HIV facial lipoatrophy, smile lines and other facial wrinkles, and cheek volume deficit; neck, body, and buttock uses are off-label.